Peripheral blood mononuclear cells from patients with multiple sclerosis show decreased activation of STAT4 by interferon-beta and reduced expression of interferon type 1 receptor

被引：0
|
作者：
Fahey, A. J. [1 ]
Robins, A. [1 ]
Constantinescu, C. S. [1 ]
机构：
[1] Univ Nottingham, Nottingham NG7 2RD, England
来源：
MULTIPLE SCLEROSIS | 2006年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S195 / S196
页数：2
相关论文
共 50 条
  • [21] Interferon-beta reduces peripheral blood IFN-γ and IL-17-producing T cells in patients with multiple sclerosis
    Song, Z. Y.
    Doi, H.
    Yoshimura, S.
    Tateishi, T.
    Yonekawa, T.
    Matsushita, T.
    Kira, J.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 674 - 674
  • [22] Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta
    Saraste, M.
    Irjala, H.
    Airas, L.
    NEUROLOGICAL SCIENCES, 2007, 28 (03) : 121 - 126
  • [23] Baseline gene expression signatures in monocytes from multiple sclerosis patients treated with interferon-beta
    Bustamante, M. F.
    Nurtdinov, R. N.
    Rio, J.
    Tintore, M.
    Montalban, X.
    Comabella, M.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S235 - S235
  • [24] Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta
    Bustamante, Marta F.
    Nurtdinov, Ramil N.
    Rio, Jordi
    Montalban, Xavier
    Comabella, Manuel
    PLOS ONE, 2013, 8 (04):
  • [25] Effect of interferon-beta on endogenous catecholamines in human peripheral blood mononuclear cells: interaction with interferon-gamma and relevance for activation-induced apoptosis
    Cosentino, M
    Zaffaroni, M
    Marino, F
    Ferrari, M
    Bombelli, R
    Rasini, E
    Carcano, E
    Colombo, C
    Lecchini, S
    Ghezzi, A
    Comi, G
    Frigo, G
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 127 - 127
  • [26] Time-course differential gene expression patterns of peripheral blood mononuclear cells from interferon-beta 1a (IM) treated multiple sclerosis patients disclose potential therapy related biomarker genes
    Goertsches, R.
    Koczan, D.
    Ernst, M.
    Serrano-Fernandez, P.
    Moeller, S.
    Zettl, U.
    MULTIPLE SCLEROSIS, 2006, 12 : S77 - S77
  • [27] Toll Like Receptor 2 and 4 Expression in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients
    Hasheminia, Seyed Javad
    Zarkesh-Esfahani, Sayyed Hamid
    Tolouei, Sepideh
    Shaygannejad, Vahid
    Shirzad, Hedaiatallah
    Chaleshtory, Morteza Hashemzadeh
    IRANIAN JOURNAL OF IMMUNOLOGY, 2014, 11 (02) : 74 - 83
  • [28] Cell Type-Specific Gene Expression Changes in the Blood of Multiple Sclerosis Patients in the Early Phase of Interferon-beta Treatment
    Hecker, Michael
    Fitzner, Brit
    Koczan, Dirk
    Schroeder, Ina
    Thiesen, Hanssl-Juergen
    Zettl, Uwe
    NEUROLOGY, 2016, 86
  • [29] CD56 bright NK cells and natural killer receptor expression in multiple sclerosis patients treated with interferon-beta
    Martinez-Rodriguez, J. E.
    Lopez-Botet, M.
    Munteis, E.
    Rio, J.
    Roquer, J.
    Montalban, X.
    Comabella, M.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S130 - S130
  • [30] Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis
    Tanasescu, R.
    Midgley, A.
    Robins, R. A.
    Constantinescu, C. S.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (03): : 233 - 238
12345